ASSESSMENT OF THE N-TERMINAL COLLAGEN III-TYPE PROPEPTIDE IN PATIENTS WITH CHRONIC HEART FAILURE AND METABOLIC SYNDROME
Development and progress of chronic heart failure (CHF) are faster in obesity, lipid and carbohydrate metabolism disorders. The liver presentation of metabolic syndrome (MS) is the non-alcoholic fatty liver disease (NAFLD). Comorbidity of NAFLD and cardiovascular diseases leads to increase of cardio...
Saved in:
| Main Authors: | O. M. Drapkina, E. V. Zyatenkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2015-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Superior Diagnostic Efficacy of N‐Terminal Propeptide of Type III Collagen and Golgi Protein 73 for Detection of Fibrosis in Chronic Hepatitis B Patients
by: Qianqian Chen, et al.
Published: (2025-06-01) -
N-TERMINAL PROPEPTIDE OF COLLAGEN TYPE III AS A PROPOSED MARKER OF MYOCARDIAL FIBROSIS IN TYPE 2 DIABETES
by: O. M. Drapkina, et al.
Published: (2018-06-01) -
The involvement of kidneys in chronic heart failure patients with liver steatosis
by: O. M. Drapkina, et al.
Published: (2016-02-01) -
Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
by: Xiao Liu, et al.
Published: (2024-11-01) -
Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)